Michael J. Catelani

Michael J. Catelani

President, Chief Operating Officer and Chief Financial OfficeratAnixa Biosciences· In proxies 2022–2025

Pay in FY2025-26% from the year before · Anixa Biosciences stock +18.0% the same year

Michael J. Catelani was paid $1.3M in FY2025 (Oct), down 26%. Anixa Biosciences stock rose 18.0% that year.

Pay$100 in the stock at the end of FY21 → $87
Pay is from the Summary Compensation Table of each Anixa Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Anixa BiosciencesPublic company · 4 yr
    • President, Chief Operating Officer and Chief Financial Officer2022 – Present · 4 yrStock in role -21%
  2. Australian Securities Exchange-listedPublic company
    • Director? – PresentNo stock prices for these years
  3. Benitec Biopharma LimitedPublic company
    • Director? – PresentNo stock prices for these years
  4. PRC ClinicalPublic company · 2 yr
    • Director2015 – 2017 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?